 |
|
 |
Jeffrey D. Dunn, PharmD, MBA |
|
|
 |
Rishi Singh, MD |
|
|
 |
Jacqueline Shaia, BS |
|
|
Virtual Journal Club: Latest Updates and Peer-to-Peer Discussions in DR/DME and AMD Management - Diabetic Retinopathy Trends and Disparities in Younger Patients: The Implications for Managed Care
| Expert Faculty Presenters | ||||||||||||||
|
||||||||||||||
Target Audience
This activity is designed to meet the educational needs of managed care pharmacy directors, registered nurses, clinical pharmacists, quality directors and medical directors.
Statement of Need/Program Overview
Managed care professionals are tasked with staying up-to-date on multiple disease states to improve care management for large and diverse patient populations. Therefore, managed care professionals can benefit from timely educational opportunities that focus on the latest clinical updates and payer implications through peer-to-peer discussion to stay informed. In retinal disease management, specifically DR, payers need increased knowledge and competence to improve access and care for certain patient populations, including younger patients and underserved communities. This activity is focused on the results of one recent study focused on longitudinal trends and disparities in DR which showed an increase in the incidence of DR in younger patients (ages 20-39 years) and racial and ethnic minoritized patients. Clinical and managed care experts will review the study results and article below and discuss opportunities for managed care strategies to improve outcomes for these patients.
Pre-read Article: Longitudinal Trends and Disparities in Diabetic Retinopathy Within an Aggregate Health Care Network
Educational Objectives
After completing this activity, the participant should be better able to:
Accreditation Information
 |
Joint Accreditation Statement |
Physician Continuing Medical Education
Medical Education Resources designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Pharmacy Education
Medical Education Resources designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
UAN: JA0003680-9999-25-050-H01-P
Activity Type: Knowledge-based
Continuing Nursing Education
Medical Education Resources designates this enduring material for a maximum of 1.0 ANCC nursing contact hour. Nurses will be awarded contact hour upon successful completion of the activity.
Medical Education Resources is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 12299, for 1.0 contact hour.
DISCLOSURE OF CONFLICTS OF INTEREST
Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies all financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported financial relationships are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of an ineligible company.
The authors reported the following financial relationships with ineligible companies whose products or services may be mentioned in this activity:
| Name of Working Group Members/Planners | Reported Financial Relationship |
|---|---|
| Jeffrey D. Dunn, PharmD, MBA | Jeffrey Dunn, PharmD, MBA has nothing to disclose |
| Rishi Singh, MD | Rishi Singh, MD has Consultation Appointments with: Alcon; Genentech; Regeneron; Apellis Consultant; Iveric/Astellas; 4DMT; RegnX Bio; Unity; Janssen |
| Jacqueline Shaia, BS | Jacqueline Shaia, BS has nothing to disclose |
The content managers reported the following financial relationships with ineligible companies whose products or services may be mentioned in this activity:
| Name of Content Managers | Reported Financial Relationship |
|---|---|
| Impact Education, LLC. | No financial relationships to disclose |
| Planners at Medical Education Resources | No financial relationships to disclose |
METHOD OF PARTICIPATION
There are no fees for participating in and receiving credit for this activity. During the accreditation period, participants must 1) read the learning objectives and faculty disclosures, 2) study the educational activity, and 3) complete the evaluation form.
A statement of credit will be issued only upon receipt of a completed activity evaluation form.
DISCLAIMER
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources, Impact Education, LLC, and/or Regeneron Pharmaceuticals, Inc. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.
FEE INFORMATION
There is no fee for this activity.